Old Web
English
Sign In
Acemap
>
Paper
>
Bcr-Abl inhibition as a modality of CML therapeutics
Bcr-Abl inhibition as a modality of CML therapeutics
2001
Elisabeth Buchdunger
Alex Matter
Brian J. Druker
Keywords:
Chronic myelogenous leukemia
ABL
breakpoint cluster region
Cancer research
Tyrosine-kinase inhibitor
Biology
Molecular biology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
34
References
92
Citations
NaN
KQI
[]